Posttreatment ultrasound-detected residual venous thrombosis: A risk factor for recurrent venous thromboembolism and mortality

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 5, 2007, Pages 403-408

  Savory, Laura ^a,b   Harper, Paul ^b,d   Ockelford, Paul ^a,b,c,e  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Diagnostic Medlab   (New Zealand)

^d PALMERSTON NORTH HOSPITAL   (New Zealand)

^e c/o Diagnostic Medlab ^*  (New Zealand)

Author keywords

Compression ultrasound scanning; Predicting recurrent venous thrombosis; Residual posttreatment venous thrombosis; Risk recurrence in VTE

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; D DIMER; WARFARIN;

ANTICOAGULANT THERAPY; ARTERY DISEASE; ATHEROSCLEROSIS; CANCER; DEATH; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; HUMAN; LUNG EMBOLISM; MORTALITY; PREDICTION; PROBABILITY; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HUMANS; PULMONARY EMBOLISM; RECURRENCE; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 34748903560     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32821642fb     Document Type: Review

References (54)

1. Goldhaber SZ. Prevention of recurrent idiopathic venous thromboembolism. Circulation 2004; 110 (24 Suppl 1):IV20-IV24.
2. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7. [see comment].
3. Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82:423-428.
4. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362:523-526.
5. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117:19-25.
6. Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160:769-774.
7. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160:761-768.
8. Kearon C, Ginsberg JS, Anderson DR, et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost 2004; 2:743-749.
9. Schulman S, Rhedin AS, Lindmarker P, et al., Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332:1661-1665. [see comment].
10. Franzeck UK, Schalch I, Jager KA, et al. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zurich study). Circulation 1996; 93:74-79.
11. Arcelus JI, Caprini JA, Hoffman KN, et al. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg 1996; 23:616-621.
12. Haenen JH, Wollersheim H, Janssen MC, et al. Evolution of deep venous thrombosis: a 2-year follow-up using duplex ultrasound scan and strain-gauge plethysmography. J Vasc Surg 2001; 34:649-655.
13. Piovella F, Crippa L, Barone M, et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 2002; 87:515-522.
14. Markel A, Meissner M, Manzo RA, et al. Deep venous thrombosis: rate of spontaneous lysis and thrombus extension. Int Angiol 2003; 22:376-382.
15. Mantoni M. Deep venous thrombosis: longitudinal study with duplex US. Radiology 1991; 179:271-273.
16. O'Shaughnessy AM, Fitzgerald DE. The patterns and distribution of residual abnormalities between the individual proximal venous segments after an acute deep vein thrombosis. J Vasc Surg 2001; 33:379-384.
17. Caps MT, Meissner MH, Tullis MJ, et al. Venous thrombus stability during acute phase of therapy. Vasc Med 1999; 4:9-14.
18. Van Ramshorst B, van Bemmelen PS, Hoeneveld H, et al. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation 1992; 86:414-419.
19. Asbeutah AM, Riha AZ, Cameron JD, McGrath BP. Five-year outcome study of deep vein thrombosis in the lower limbs. J Vasc Surg 2004; 40:1184-1189.
20. O'Shaughnessy AM, Fitzgerald DE. Underlying factors influencing the development of the postthrombotic limb. J Vasc Surg 2001; 34:247-253.
21. Galli M, Ageno W, Squizzato A, et al. Residual venous obstruction in patients with a single episode of deep vein thrombosis and in patients with recurrent deep vein thrombosis. Thromb Haemost 2005; 94:93-95.
22. Prandoni P. Risk factors of recurrent venous thromboembolism: the role of residual vein thrombosis. Pathophysiol Haemost Thromb 2003; 33:351-353.
23. Prandoni P, Lensing AWA, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. [see comment; summary for patients in Ann Intern Med 2002; 137:I32]. Ann Intern Med 2002; 137:955-960.
24. Cosmi B, Legnani C, Cini M, et al. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost 2005; 94:969-974.
25. Prandoni P, Cogo A, Bernardi E, et al. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation 1993; 88 (4 Pt 1):1730-1735.
26. Prandoni P, Lensing AWA, Bernardi E, et al. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 2002; 88:402-406.
27. Cosmi B, Legnani C, Cini M, et al. The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawl in cancer patients. Haematologica 2005; 90:713-715.
28. Young L, Ockelford P, Milne D, et al. Posttreatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost 2006; 4:1919-1924. A cohort of patients from our group showing a correlation between residual thrombus and recurrence and also an increased risk of death.
29. Lopez J, Kearon C, Lee A. Deep venous thrombosis. In: Hematology: American Society of Hematology Education Program Book, Annual Meeting, 4-7 December 2004, San Diego, CA. Washington, DC: American Society of Hematology; 2004. pp. 439-456.
30. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. [see comment; erratum appears in N Engl J Med 1999; 341:298]. N Engl J Med 1999; 340:901-907.
31. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349:631-639. [see comment].
32. Phillips GW. Review of venous vascular ultrasound. World J Surg 2000; 24:241-248.
33. Bosson JL, Riachi M, Pichot O, et al. Diameters of acute proximal and distal deep venous thrombosis of the lower limbs. Int Angiol 1998; 17:260-267.
34. Haenen JH, van Langen H, Janssen MC, et al. Venous duplex scanning of the leg: range, variability and reproducibility. Clin Sci 1999; 96:271-277.
35. Linkins L-A, Stretton R, Probyn L, Kearon C. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res 2006; 117:241-247.
36. Lindmarker P, Schulman S, DURAC Trial Study Group. The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg. J Intern Med 2000; 247:601-606.
37. Breddin HK, Kadziola Z, Scully M, et al. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis. Thromb Haemost 2003; 89:272-277.
38. Barcellona D, Fenu L, Cauli C, et al. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost 2003; 90:1061-1064.
39. Folsom AR, Cushman M, Heckbert SR, et al. Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol 2003; 56:598-603.
40. Lowe GDO. Arterial disease and venous thrombosis: are they related, and if so, what should we do about it? J Thromb Haemost 2006; 4:1882-1885. An interesting editorial examining the correlation between arterial and venous disease.
41. Lowe GDO. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006; 133:232-250.
42. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2:533-537. [see comment].
43. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al., The Worcester DVT Study. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1991; 151:933-938.
44. Schulman S, Lindmarker P, Holmstrom M, et al. Postthrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4:734-742. [see comment]. Recent update of an early key study of warfarin duration, including a correlation with recurrence and mortality.
45. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348:1435-1441. [see comment].
46. Reich LM, Folsom AR, Key NS, et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 2006; 4:1909-1913. [see comment]. One of two studies published simultaneously which, in contrast to reference 45 did not show a correlation between arterial atheroma and idiopathic VTE.
47. Van der Hagen PB, Folsom AR, Jenny NS, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006; 4:1903-1908. [see comment]. One of two studies published simultaneously which, in contrast to reference 45, did not show a correlation between arterial atheroma and idiopathic VTE.
48. Becattini C, Agnelli G, Prandoni P, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005; 26:77-83. [see comment].
49. Prandoni P, Ghirarduzzi A, Prins MH, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006; 4:1891-1896. [see comment]. Important paper examining the risk of arterial events in patients with VTE from a different group and with similar results to [48].
50. •] examining the potential association between arterial and venous vascular events.
51. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. [see comment; erratum appears in Br Med J 2002; 324:141]. Br Med J 2002; 324:71-86.
52. Hovens MMC, Snoep JD, Tamsma JT, Huisman MV. Aspirin in the prevention and treatment of venous thromboembolism. J Thromb Haemost 2006; 4:1470-1475.
53. Brighton T, Eikelboom J, Gallus A, et al. Low-dose aspirin for secondary prevention of vein thrombosis - a prospectively planned meta-analysis [abstract]. J Thromb Haemost 2005; 3 (Suppl 1):2202.
54. Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348:1425-1434. [see comment].